ASCO 2020: Update on Genitourinary Cancers | Supplements And Featured Publications

COSMIC-021 Data Affirm Activity of Cabozantinib/Atezolizumab in mCRPC

June 08, 2020

Neeraj Agarwal, MD, discusses the COSMIC-021 trial, the findings from cohort 6 in metastatic castration-resistant prostate cancer, and the planned phase 3 trial that will evaluate the combination on a larger scale.